June 25, 2014 - Stem Cell Therapy / David Steenblock By: Dennis Courtney … Continue reading →

Animal Cell Therapies - Tucker's Story Tucker shows notable improvement in gait and movement after receiving stem cell therapy from Animal Cell Therapies. By: Animal Cell Therapies, Inc. … Continue reading →

Animal Cell Therapies - She-Dog's Stem Cell Treatment Story She-dog was rescued from the streets and had some pretty severe health issues when she walked in the door. A couple months after her stem cell treatment from... By: Animal Cell Therapies, Inc. … Continue reading →

TOKYO: Japanese stem cell scientists have succeeded in slowing the deterioration of mice with motor neuron disease, possibly paving the way for eventual human treatment, according to a new paper. A team of researchers from the Kyoto University and Keio University transplanted specially created cells into mice with amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's, or motor neuron disease. The progress of the creatures' neurological degeneration was slowed by almost eight per cent, according to the paper, which was published on Thursday in the scholarly journal Stem Cell Reports. ALS is a disorder of motor neurons -- nerves that control movement -- leading to the loss of the ability to control muscles and their eventual atrophy. While it frequently has no effect on cognitive function, it progresses to affect most of the muscles in the body, including those used to eat and breathe. British theoretical physicist Stephen Hawking has been almost completely paralysed by the condition. In their study, the Japanese team used human "iPS" -- induced pluripotent stem cells, building-block cells akin to those found in embryos, which have the potential to turn into any cell in the body. From the iPS cells they created special progenitor cells … Continue reading →

Friday 27 June 2014 22.31 Japanese stem cell scientists have succeeded in slowing the deterioration of mice with motor neurone disease, possibly paving the way for eventual human treatment. A team of researchers from the Kyoto University and Keio University transplanted specially created cells into mice with amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's, or motor neurone disease. The progress of the creatures' neurological degeneration was slowed by almost eight percent, according to the paper, which was published Thursday in the scholarly journal Stem Cell Reports. ALS is a disorder of motor neurones -- nerves that control movement -- leading to the loss of the ability to control muscles and their eventual atrophy. While it frequently has no effect on cognitive function, it progresses to affect most of the muscles in the body, including those used to eat and breathe. British theoretical physicist Stephen Hawking has been almost completely paralysed by the condition. In their study, the Japanese team used human "iPS" -- induced pluripotent stem cells, building-block cells akin to those found in embryos, which have the potential to turn into any cell in the body. From the iPS cells they created special progenitor cells and transplanted them … Continue reading →

FDA notified of scientist at US pharma company (ANSA) - Rome, June 27 - Italian pharmaceutical watchdog AIFA has alerted the US Food and Drug Administration (FDA) that an Italian scientist at an American drug company was presumed to be involved in the "bogus" Stamina stem-cell treatment it banned in 2012, according to a letter seen by ANSA on Friday. Dated January 2014, the letter says Camillo Ricordi, a member of the scientific board of Bioheart and a University of Miami professor, was involved in supporting Stamina. "It's an example of how individuals and organizations in the US are supporting (Stamina) dealers offshore," said AIFA chief Luca Pani. Stamina's credibility has long been suspect, and last fall the health ministry ruled that the Stamina Foundation would no longer be allowed to test the treatment on humans. The foundation was also stripped of its non-profit status after a study found its treatment was "ignorant of stem-cell biology". Recent investigations have shown risks of the treatment range from nausea to cancer, and as many as one-quarter of all patients treated have experienced "adverse effects". The head of the foundation, Davide Vannoni, may face indictment. In April, after study results became known, hospitals … Continue reading →